Recent advances in glucose management are reshaping our understanding of cognitive decline and dementia prevention. Energy ...

Loss of beta cell function serves as the basis for progression from normal glucose tolerance to impaired glucose tolerance, but insulin clearance may not be a major factor in the development of ...

In a groundbreaking study, a research team at KAIST has uncovered a gut-brain circuit that enables the brain to selectively ...

On June 19, Beta Bionics Inc. (NASDAQ:BBNX) announced its plan to integrate its iLet Bionic Pancreas automated insulin delivery/AID system with Abbott’s future dual glucose-ketone sensor in the US.

Scientists have confirmed the existence of progenitor cells within the human pancreas that can be stimulated to develop into glucose-responsive beta cells. These significant findings open the door ...

Beta Bionics, Inc. has announced plans to integrate its iLet Bionic Pancreas automated insulin delivery system with Abbott’s upcoming dual glucose-ketone sensor in the United States.

ADA: Beta Bionics' automated insulin pump slashes glucose levels, diabetes distress in Type 1 patients By Andrea Park Jun 10, 2022 1:35pm ...

When the B6 production was turned off in first-responder cells in the pancreas of both zebrafish and mice, they found that the beta cells’ response to rising glucose levels was reduced. “This ...

Beta Bionics Announces Agreement with Abbott to Integrate the iLet Bionic Pancreas with Abbott’s Future Dual Glucose-Ketone Sensor Provided by GlobeNewswire Jun 19, 2025, 11:00:00 AM ...

On June 19, Beta Bionics Inc. (NASDAQ:BBNX) announced its plan to integrate its iLet Bionic Pancreas automated insulin delivery/AID system with Abbott’s future dual glucose-ketone sensor in the US.